ADMET (Absorption, Distribution, Metabolism, Elimination, Toxicity) research forms a critical part of drug discovery and development.

In vitro, ADME-Tox and DMPK studies are no longer late-stage regulatory requirements but are now an essential part of early discovery. We offer a comprehensive range of products and services for ADME-Tox research suitable to support regulatory approval, and advance discovery.

We offer a range of human biomaterials to support this new approach to early-stage ADME-Tox including:

  • Hepatocytes
  • Skin
  • Cell Products

We’re here to help

Talk to one of our team members and find out more.

We can help in all areas of your drug discovery and development